| Year |
Citation |
Score |
| 2022 |
Brodeur S, Vanasse A, Courteau J, Stip E, Lesage A, Fleury MJ, Courteau M, Roy MA. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. Acta Psychiatrica Scandinavica. PMID 35158404 DOI: 10.1111/acps.13413 |
0.399 |
|
| 2022 |
Brodeur S, Vanasse A, Courteau J, Courteau M, Stip E, Fleury MJ, Lesage A, Demers MF, Roy MA. Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach. Acta Psychiatrica Scandinavica. PMID 35152415 DOI: 10.1111/acps.13411 |
0.373 |
|
| 2022 |
Brodeur S, Courteau J, Vanasse A, Courteau M, Stip E, Fleury MJ, Lesage A, Demers MF, Corbeil O, Béchard L, Roy MA. Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 35082000 DOI: 10.1192/bjp.2022.1 |
0.37 |
|
| 2021 |
Lesage A, Courteau J, Brodeur S, Stip E, Fleury MJ, Courteau M, Roy MA, Vanasse A. Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211040606. PMID 34482764 DOI: 10.1177/07067437211040606 |
0.314 |
|
| 2020 |
Abdel-Baki A, Medrano S, Maranda C, Ladouceur M, Tahir R, Stip E, Potvin S. Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis. International Clinical Psychopharmacology. PMID 32282448 DOI: 10.1097/Yic.0000000000000310 |
0.363 |
|
| 2019 |
Abdel-Baki A, Thibault D, Medrano S, Stip E, Ladouceur M, Tahir R, Potvin S. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder. Early Intervention in Psychiatry. PMID 31125513 DOI: 10.1111/Eip.12826 |
0.375 |
|
| 2019 |
Stip E, Abdel-Baki A, Roy MA, Bloom D, Grignon S. [Long-acting antipsychotics: The QAAPAPLE algorithm review]. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719847193. PMID 31088133 DOI: 10.1177/0706743719847193 |
0.31 |
|
| 2019 |
Stip E, Miron JP, Nolin M, Letourneau G, Bernazzani O, Chamelian L, Boileau B, Gupta M, Luck D, Lungu O. Incidentaloma Discoveries in the Course of Neuroimaging Research. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-5. PMID 30932801 DOI: 10.1017/Cjn.2018.397 |
0.31 |
|
| 2019 |
Tikàsz A, Dumais A, Lipp O, Stip E, Lalonde P, Laurelli M, Lungu O, Potvin S. Reward-related decision-making in schizophrenia: A multimodal neuroimaging study. Psychiatry Research. Neuroimaging. 286: 45-52. PMID 30897449 DOI: 10.1016/J.Pscychresns.2019.03.007 |
0.498 |
|
| 2018 |
Stip E, Lachaine J. Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in Quebec. Therapeutic Advances in Psychopharmacology. 8: 287-301. PMID 30344996 DOI: 10.1177/2045125318782694 |
0.456 |
|
| 2018 |
Tourjman SV, Potvin S, Corbalan F, Djouini A, Purdon SE, Stip E, Juster RP, Kouassi E. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry. Attention Deficit and Hyperactivity Disorders. PMID 30225804 DOI: 10.1007/S12402-018-0268-7 |
0.354 |
|
| 2018 |
Tourjman SV, Juster RP, Purdon S, Stip E, Kouassi E, Potvin S. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. International Journal of Psychiatry in Clinical Practice. 1-8. PMID 29553848 DOI: 10.1080/13651501.2018.1450512 |
0.345 |
|
| 2018 |
Romain AJ, Fankam C, Karelis A, Letendre E, Mikolajacks G, Stip E, Abdel-Baki A. 11.1 EFFECT OF INTERVAL TRAINING ON METABOLIC RISK FACTORS IN OVERWEIGHT INDIVIDUALS WITH PSYCHOSIS: A RANDOMIZED CONTROLLED TRIAL Schizophrenia Bulletin. 44: S17-S17. DOI: 10.1093/Schbul/Sby014.039 |
0.308 |
|
| 2017 |
Stip E, Blain-Juste ME, Farmer O, Fournier-Gosselin MP, Lespérance P. Catatonia with schizophrenia: From ECT to rTMS. L'Encephale. PMID 29241672 DOI: 10.1016/J.Encep.2017.09.008 |
0.442 |
|
| 2017 |
Potvin S, Tikàsz A, Lungu O, Stip E, Zaharieva V, Lalonde P, Lipp O, Mendrek A. Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images. Frontiers in Psychiatry. 8: 109. PMID 28674507 DOI: 10.3389/Fpsyt.2017.00109 |
0.444 |
|
| 2017 |
Stip E, Caron J, Tousignant M, Lecomte Y. Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717715207. PMID 28673099 DOI: 10.1177/0706743717715207 |
0.427 |
|
| 2017 |
Orban P, Dansereau C, Desbois L, Mongeau-Pérusse V, Giguère CÉ, Nguyen H, Mendrek A, Stip E, Bellec P. Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivity. Schizophrenia Research. PMID 28601499 DOI: 10.1016/J.Schres.2017.05.027 |
0.407 |
|
| 2017 |
Stip E, Cherbal A, Luck D, Zhornitsky S, Bentaleb LA, Lungu O. A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment. Psychopharmacology. PMID 28210783 DOI: 10.1007/S00213-017-4533-9 |
0.461 |
|
| 2016 |
Potvin S, Stip E, Marchand S. Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia. Case Reports in Psychiatry. 2016: 8702483. PMID 27144045 DOI: 10.1155/2016/8702483 |
0.4 |
|
| 2016 |
Orban P, Desseilles M, Mendrek A, Bourque J, Bellec P, Stip E. Altered brain connectivity in patients with schizophrenia is consistent across cognitive contexts. Journal of Psychiatry & Neuroscience : Jpn. 41: 150247. PMID 27091719 DOI: 10.1503/Jpn.150247 |
0.461 |
|
| 2016 |
Potvin S, Lungu O, Lipp O, Lalonde P, Zaharieva V, Stip E, Melun JP, Mendrek A. Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. Schizophrenia Research. 173: 30-6. PMID 27005897 DOI: 10.1016/J.Schres.2016.03.011 |
0.426 |
|
| 2016 |
Stip E, Thibault A, Beauchamp-Chatel A, Kisely S. Internet Addiction, Hikikomori Syndrome, and the Prodromal Phase of Psychosis. Frontiers in Psychiatry. 7: 6. PMID 26973544 DOI: 10.3389/Fpsyt.2016.00006 |
0.378 |
|
| 2016 |
Potvin S, Aubin G, Stip E. [Subjective cognition in schizophrenia]. L'Encephale. 43: 15-20. PMID 26923995 DOI: 10.1016/J.Encep.2016.01.002 |
0.515 |
|
| 2016 |
Chalfoun C, Karelis AD, Stip E, Abdel-Baki A. Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia. Journal of Sports Sciences. 34: 1500-15. PMID 26630458 DOI: 10.1080/02640414.2015.1119875 |
0.376 |
|
| 2016 |
Lachaine J, Larbi M, Melnyk P, Rouleau A, Baribeau V, Stip E. Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia Value in Health. 19: A605. DOI: 10.1016/J.Jval.2016.09.1489 |
0.392 |
|
| 2015 |
Scherzer P, Achim A, Léveillé E, Boisseau E, Stip E. Evidence from paranoid schizophrenia for more than one component of theory of mind. Frontiers in Psychology. 6: 1643. PMID 26579026 DOI: 10.3389/Fpsyg.2015.01643 |
0.366 |
|
| 2015 |
Potvin S, Tikàsz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study. Schizophrenia Research. 168: 377-80. PMID 26255082 DOI: 10.1016/J.Schres.2015.07.046 |
0.438 |
|
| 2015 |
Mancini-Marïe A, Yoon U, Jiminez J, Fahim C, Potvin S, Grant JA, Laverdure-Dupont D, Dubé AA, Betrisey C, Rainville P, Evans AC, Stip E, Mendrek A. Sex, age, symptoms and illness duration and their relation with gyrification index in schizophrenia. Clinical Schizophrenia & Related Psychoses. PMID 26218234 DOI: 10.3371/Csrp.Mayo.070415 |
0.504 |
|
| 2015 |
Stip E, Lungu OV. Salience network and olanzapine in schizophrenia: implications for treatment in anorexia nervosa. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S35-9. PMID 25886678 |
0.394 |
|
| 2015 |
Stip E, Potvin S. The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S1-4. PMID 25886674 |
0.376 |
|
| 2015 |
Potvin S, Lungu OV, Stip E. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. Journal of Clinical Psychopharmacology. 35: 82-3. PMID 25370126 DOI: 10.1097/Jcp.0000000000000236 |
0.416 |
|
| 2015 |
Potvin S, Aubin G, Stip E. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. European Archives of Psychiatry and Clinical Neuroscience. 265: 147-54. PMID 24925606 DOI: 10.1007/S00406-014-0511-Y |
0.551 |
|
| 2014 |
Potvin S, Pelletier J, Stip E. [Neurocognitive insight in schizophrenia: a meta-analysis]. Santé Mentale Au QuéBec. 39: 183-200. PMID 25590551 |
0.394 |
|
| 2014 |
Potvin S, Pelletier J, Stip E. La conscience des déficits neurocognitifs dans la schizophrénie : une méta-analyse MosaïQue. 39: 183-200. DOI: 10.7202/1027839Ar |
0.332 |
|
| 2014 |
Aubin G, Lamoureux J, Gélinas I, Chapparo C, Stip E, Rainville C. Daily task performance and information processing among people with schizophrenia and healthy controls: A comparative study British Journal of Occupational Therapy. 77: 466-474. DOI: 10.4276/030802214X14098207541117 |
0.418 |
|
| 2013 |
Potvin S, Bourque J, Durand M, Lipp O, Lalonde P, Stip E, Grignon S, Mendrek A. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia Research and Treatment. 2013: 543842. PMID 23970971 DOI: 10.1155/2013/543842 |
0.545 |
|
| 2013 |
Stip E, Vincent PD, Sablier J, Guevremont C, Zhornitsky S, Tranulis C. A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia. Frontiers in Pharmacology. 4: 100. PMID 23950746 DOI: 10.3389/Fphar.2013.00100 |
0.44 |
|
| 2013 |
Bourque J, Mendrek A, Durand M, Lakis N, Lipp O, Stip E, Lalonde P, Grignon S, Potvin S. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry Research. 214: 24-32. PMID 23906663 DOI: 10.1016/J.Pscychresns.2013.05.012 |
0.483 |
|
| 2013 |
Petersen KL, Nicholls TL, Groden D, Schmitz N, Stip E, Goldner EM, Arnold LM, Lesage A. Redevelopment of tertiary psychiatric services in British Columbia: a prospective study of clinical, social, and residential outcomes of former long-stay inpatients. Schizophrenia Research. 149: 96-103. PMID 23815971 DOI: 10.1016/J.Schres.2013.05.022 |
0.334 |
|
| 2013 |
Malla A, Chue P, Jordan G, Stip E, Koczerginski D, Milliken H, Joseph A, Williams R, Adams B, Manchanda R, Oyewumi K, Roy MA. An Exploratory Open-Label Randomized Trial Comparing Risperidone Long Acting Injectable (RLAI) with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clinical Schizophrenia & Related Psychoses. 1-26. PMID 23773886 DOI: 10.3371/Csrp.Mach.061213 |
0.37 |
|
| 2013 |
Guillaume F, Stip E, Tiberghien G. About the nature of contextual impairments revealed by FN400 abnormalities in schizophrenia. Frontiers in Human Neuroscience. 7: 60. PMID 23460768 DOI: 10.3389/Fnhum.2013.00060 |
0.446 |
|
| 2013 |
Bourque J, Lakis N, Champagne J, Stip E, Lalonde P, Lipp O, Mendrek A. Clozapine and visuospatial processing in treatment-resistant schizophrenia. Cognitive Neuropsychiatry. 18: 615-30. PMID 23343453 DOI: 10.1080/13546805.2012.760917 |
0.489 |
|
| 2013 |
Chue P, Malla A, Bouchard RH, Lessard S, Ganesan S, Stip E, Johnson S, Chen E, Ahn YM, Kim YS, Robinson G, Schweikert C, Gendron A, Eriksson H. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia. Current Medical Research and Opinion. 29: 227-39. PMID 23281876 DOI: 10.1185/03007995.2012.762903 |
0.347 |
|
| 2013 |
Zhornitsky S, Aubin G, Desfossés J, Rizkallah E, Pampoulova T, Lipp O, Chiasson JP, Stip E, Potvin S. Predictors of community functioning in schizophrenia and substance use disorder patients. Community Mental Health Journal. 49: 317-22. PMID 22847727 DOI: 10.1007/S10597-012-9525-Y |
0.498 |
|
| 2013 |
Lungu O, Anselmo K, Letourneau G, Mendrek A, Stip B, Lipp O, Lalonde P, Ait Bentaleb L, Stip E. Neuronal correlates of appetite regulation in patients with schizophrenia: is there a basis for future appetite dysfunction? European Psychiatry : the Journal of the Association of European Psychiatrists. 28: 293-301. PMID 22542330 DOI: 10.1016/J.Eurpsy.2012.02.001 |
0.461 |
|
| 2013 |
Lungu O, Barakat M, Laventure S, Debas K, Proulx S, Luck D, Stip E. The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literature. Schizophrenia Bulletin. 39: 797-806. PMID 22267533 DOI: 10.1093/Schbul/Sbr193 |
0.534 |
|
| 2012 |
Lévesque M, Potvin S, Marchand S, Stip E, Grignon S, Pierre L, Lipp O, Goffaux P. Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Medicine (Malden, Mass.). 13: 1571-9. PMID 23170852 DOI: 10.1111/J.1526-4637.2012.01505.X |
0.316 |
|
| 2012 |
Scherzer P, Leveillé E, Achim A, Boisseau E, Stip E. A study of theory of mind in paranoid schizophrenia: a theory or many theories? Frontiers in Psychology. 3: 432. PMID 23162496 DOI: 10.3389/Fpsyg.2012.00432 |
0.475 |
|
| 2012 |
Desfossés J, Stip E, Bentaleb LA, Lipp O, Chiasson JP, Furtos A, Venne K, Kouassi E, Potvin S. Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. Frontiers in Psychiatry. 3: 85. PMID 23055987 DOI: 10.3389/Fpsyt.2012.00085 |
0.541 |
|
| 2012 |
Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Lipp O, Stip E, Potvin S. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Research. 200: 237-41. PMID 22980481 DOI: 10.1016/J.Psychres.2012.07.046 |
0.498 |
|
| 2012 |
Moteshafi H, Zhornitsky S, Brunelle S, Stip E. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Safety. 35: 819-36. PMID 22967188 DOI: 10.2165/11631510-000000000-00000 |
0.432 |
|
| 2012 |
Champagne J, Lakis N, Bourque J, Stip E, Lipp O, Mendrek A. Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia. Schizophrenia Research and Treatment. 2012: 917901. PMID 22966452 DOI: 10.1155/2012/917901 |
0.421 |
|
| 2012 |
Zhornitsky S, Stip E. Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. Schizophrenia Research and Treatment. 2012: 407171. PMID 22966436 DOI: 10.1155/2012/407171 |
0.42 |
|
| 2012 |
Moteshafi H, Stip E. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert Opinion On Drug Safety. 11: 713-32. PMID 22913713 DOI: 10.1517/14740338.2012.712682 |
0.491 |
|
| 2012 |
Sablier J, Stip E, Jacquet P, Giroux S, Pigot H, Franck N. Ecological assessments of activities of daily living and personal experiences with Mobus, an assistive technology for cognition: a pilot study in schizophrenia. Assistive Technology : the Official Journal of Resna. 24: 67-77. PMID 22876729 DOI: 10.1080/10400435.2012.659324 |
0.464 |
|
| 2012 |
Stip E, Lungu OV, Anselmo K, Letourneau G, Mendrek A, Stip B, Lipp O, Lalonde P, Bentaleb LA. Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment Translational Psychiatry. 2. PMID 22714121 DOI: 10.1038/Tp.2012.53 |
0.386 |
|
| 2012 |
Guillaume F, Guillem F, Tiberghien G, Stip E. Mismatched expressions decrease face recognition and corresponding ERP old/new effects in schizophrenia. Neuropsychology. 26: 568-77. PMID 22686352 DOI: 10.1037/A0028924 |
0.429 |
|
| 2012 |
Lungu O, Stip E. Agenesis of corpus callosum and emotional information processing in schizophrenia. Frontiers in Psychiatry. 3: 1. PMID 22347194 DOI: 10.3389/Fpsyt.2012.00001 |
0.4 |
|
| 2012 |
Guillaume F, Guillem F, Tiberghien G, Stip E. ERP investigation of study-test background mismatch during face recognition in schizophrenia. Schizophrenia Research. 134: 101-9. PMID 22079945 DOI: 10.1016/J.Schres.2011.10.010 |
0.404 |
|
| 2012 |
Honer WG, MacEwan GW, Gendron A, Stip E, Labelle A, Williams R, Eriksson H. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. The Journal of Clinical Psychiatry. 73: 13-20. PMID 21733490 DOI: 10.4088/Jcp.10M06194 |
0.343 |
|
| 2012 |
Moteshafi H, Stip E. Comparing second generation antipsychotics metabolic side effects in bipolar disorders and schizophrenia International Clinical Psychopharmacology. 28: e52-e53. DOI: 10.1097/01.YIC.0000423336.47096.A6 |
0.379 |
|
| 2012 |
Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: A clinical-profile analysis incorporating impulsivity and substance-use disorders | Esquizofrenia y violencia grave: un análisis del perfil clínico que incorpora la impulsividad y los trastornos de consumo de sustancias Psiquiatria Biologica. 19: 65-68. DOI: 10.1016/J.Psiq.2012.06.003 |
0.314 |
|
| 2011 |
Letourneau G, Bentaleb LA, Stip B, Luck D, Stip E. Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study. Schizophrenia Research and Treatment. 2011: 862350. PMID 22937275 DOI: 10.1155/2011/862350 |
0.437 |
|
| 2011 |
Stip E, Zhornitsky S, Moteshafi H, Létourneau G, Stikarovska I, Potvin S, Tourjman V. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile. Clinical Therapeutics. 33: 1853-67. PMID 22133697 DOI: 10.1016/J.Clinthera.2011.10.027 |
0.342 |
|
| 2011 |
Lakis N, Jiménez JA, Mancini-Marïe A, Stip E, Lavoie ME, Mendrek A. Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal. Psychiatry Research. 194: 245-56. PMID 22079660 DOI: 10.1016/J.Pscychresns.2011.05.010 |
0.486 |
|
| 2011 |
Homayoun S, Nadeau-Marcotte F, Luck D, Stip E. Subjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link? Frontiers in Psychology. 2: 148. PMID 21779267 DOI: 10.3389/Fpsyg.2011.00148 |
0.469 |
|
| 2011 |
Stip E, Abdel-Baki A, Bloom D, Grignon S, Roy MA. [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 56: 367-76. PMID 21756451 DOI: 10.1177/070674371105600608 |
0.405 |
|
| 2011 |
Mendrek A, Stip E. Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Review of Neurotherapeutics. 11: 951-9. PMID 21721913 DOI: 10.1586/Ern.11.78 |
0.496 |
|
| 2011 |
Zhornitsky S, Stip E, Desfossés J, Pampoulova T, Rizkallah E, Rompré PP, Bentaleb LA, Lipp O, Chiasson JP, Gendron A, Potvin S. Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. Frontiers in Psychiatry. 2: 22. PMID 21629845 DOI: 10.3389/Fpsyt.2011.00022 |
0.513 |
|
| 2011 |
Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, Gendron A, Kouassi E. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1695-8. PMID 21627977 DOI: 10.1016/J.Pnpbp.2011.05.011 |
0.475 |
|
| 2011 |
Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophrenia Research. 130: 234-7. PMID 21441016 DOI: 10.1016/J.Schres.2011.02.024 |
0.43 |
|
| 2011 |
Zhornitsky S, Potvin S, Moteshafi H, Dubreucq S, Rompré PP, Stip E. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. International Clinical Psychopharmacology. 26: 183-92. PMID 21372722 DOI: 10.1097/Yic.0B013E3283430A0E |
0.374 |
|
| 2011 |
Zhornitsky S, Potvin S, Aubin G, Stip E. Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia. The Australian and New Zealand Journal of Psychiatry. 45: 604-5. PMID 21355813 DOI: 10.3109/00048674.2011.561483 |
0.495 |
|
| 2011 |
Mendrek A, Jiménez JA, Mancini-Marïe A, Fahim C, Stip E. Correlations between sadness-induced cerebral activations and schizophrenia symptoms: an fMRI study of sex differences. European Psychiatry : the Journal of the Association of European Psychiatrists. 26: 320-6. PMID 20620024 DOI: 10.1016/J.Eurpsy.2010.04.007 |
0.472 |
|
| 2011 |
Lavoie ME, Imbriglio TV, Stip E, O'Connor KP. Neurocognitive Changes Following Cognitive-Behavioral Treatment in Tourette Syndrome and Chronic Tic Disorder International Journal of Cognitive Therapy. 4: 34-50. DOI: 10.1521/Ijct.2011.4.1.34 |
0.358 |
|
| 2011 |
Mendrek A, Bourque J, Champagne J, Lakis N, Lavoie M, Lupien S, Stip E. Different role of sex steroid hormones in brain activations of schizophrenia patients and healthy controls International Clinical Psychopharmacology. 26: e166-e167. DOI: 10.1097/01.Yic.0000405927.79522.C5 |
0.443 |
|
| 2011 |
Bah R, Igue R, Potvin S, Stip E, Bouchard R, Lipp O, Gendron A, Kouassi E. Markedly elevated plasma levels of interleukin-1 receptor antagonist in patients with dual diagnosis of schizophrenia and substance use disorders International Clinical Psychopharmacology. 26: e148. DOI: 10.1097/01.Yic.0000405886.17709.24 |
0.431 |
|
| 2011 |
Cherbal A, Lungu O, Bentaleb AL, Stip E. Antipsychotic treatment with ziprasidone restores cognitive processing of emotional information in prefrontal cortex in patients with schizophrenia International Clinical Psychopharmacology. 26: e147-e148. DOI: 10.1097/01.Yic.0000405885.40580.08 |
0.473 |
|
| 2011 |
Lakis N, Jiménez J, Marië AM, Lavoie M, Lupien S, Guillem F, Stip E, Mendrek A. Neuroimaging sex differences in emotional memory in schizophrenia patients International Clinical Psychopharmacology. 26: e123-e124. DOI: 10.1097/01.Yic.0000405843.25701.Ca |
0.451 |
|
| 2011 |
Sablier J, Stip E, Franck N, Giroux S, Pigot H, Nadeau-Marcotte F. Mobus project-assistive technology for improving cognition and autonomy of patients with schizophrenia International Clinical Psychopharmacology. 26: e65-e66. DOI: 10.1097/01.Yic.0000405743.97198.55 |
0.472 |
|
| 2010 |
Briand C, Reinharz D, Lesage A, Nicole L, Stip E, Lalonde P, Villeneuve K, Planet-Sultan S. [Implementation in Quebec of the Integrated Psychological Treatment (IPT) for people with schizophrenia: five years later]. Santé Mentale Au QuéBec. 35: 145-62. PMID 21761090 DOI: 10.7202/1000557Ar |
0.39 |
|
| 2010 |
Rizkallah E, Stip E, Zhornitsky S, Pampoulova T, Gendron A, Rompré PP, Chiasson JP, Potvin S. Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion On Pharmacotherapy. 11: 2947-51. PMID 20979569 DOI: 10.1517/14656566.2010.524927 |
0.383 |
|
| 2010 |
Zhornitsky S, Stip E, Pampoulova T, Rizkallah E, Lipp O, Bentaleb LA, Chiasson JP, Potvin S. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2188-94. PMID 20669315 DOI: 10.1002/Mds.23227 |
0.498 |
|
| 2010 |
Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Stip E, Rompré PP, Potvin S. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. Journal of Clinical Psychopharmacology. 30: 417-24. PMID 20631559 DOI: 10.1097/Jcp.0B013E3181E7810A |
0.343 |
|
| 2010 |
Poulin J, Chouinard S, Pampoulova T, Lecomte Y, Stip E, Godbout R. Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Research. 179: 274-8. PMID 20493544 DOI: 10.1016/J.Psychres.2009.08.009 |
0.357 |
|
| 2010 |
Stip E, Zhornitsky S, Potvin S, Tourjman V. Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 997-1000. PMID 20470848 DOI: 10.1016/J.Pnpbp.2010.05.010 |
0.397 |
|
| 2010 |
Stip E, Tourjman V. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Clinical Therapeutics. 32: S3-20. PMID 20152550 DOI: 10.1016/J.Clinthera.2010.01.021 |
0.524 |
|
| 2010 |
Lecardeur L, Mendrek A, Stip E. Sexual dimorphism of spatial working memory profiles in schizophrenia. Cognitive Neuropsychiatry. 15: 397-405. PMID 20094930 DOI: 10.1080/13546800903399183 |
0.444 |
|
| 2010 |
Desfossés J, Stip E, Bentaleb LA, Potvin S. Endocannabinoids and Schizophrenia Pharmaceuticals. 3: 3101-3126. DOI: 10.3390/Ph3103101 |
0.495 |
|
| 2010 |
Lecardeur L, Stip E, Champagne-Lavau M. Cognitive Remediation Therapy of Social Cognition in Schizophrenia: A Critical Review Current Psychiatry Reviews. 6: 280-287. DOI: 10.2174/157340010793499369 |
0.425 |
|
| 2010 |
Sablier J, Stip E, Franck N, Group M. MOBUS PROJECT – RANDOMISED STUDY OF AN ASSISTIVE TECHNOLOGY FOR IMPROVING COGNITION AND AUTONOMY OF PATIENTS WITH SCHIZOPHRENIA: EXPLORING PRILIMINARY DATA Schizophrenia Research. 117: 512-513. DOI: 10.1016/J.Schres.2010.02.981 |
0.467 |
|
| 2010 |
Royer A, Schneider F, Mendrek A, Stip E. ALTERED COGNITIVE AND EMOTIONAL MODULATION OF BRAIN ACTIVITY IN SCHIZOPHRENIA Schizophrenia Research. 117: 468. DOI: 10.1016/J.Schres.2010.02.879 |
0.448 |
|
| 2010 |
Stip E. ADDRESS UNKNOWN: HOW A STORY REVEALS A THEORY OF MIND DEFICIT IN SCHIZOPHRENIA Schizophrenia Research. 117: 444-445. DOI: 10.1016/J.Schres.2010.02.824 |
0.477 |
|
| 2010 |
Honer WG, MacEwan GW, Gendron A, Stip E, Labelle A, Williams R, Eriksson H. A DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY AND TOLERABILITY OF QUETIAPINE 1200 MG/D VERSUS 800 MG/D IN PATIENTS WITH PERSISTENT SYMPTOMS OF SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER Schizophrenia Research. 117: 375. DOI: 10.1016/J.Schres.2010.02.670 |
0.407 |
|
| 2010 |
Stip E, Lungu OV, Anselmo K, Mendrek A, Stip B, Lipp O, Delisle M, Lalonde P, Bentaleb LA. INCREASED LIMBIC SYSTEM ACTIVITY ASSOCIATED WITH APPETITE DYSFUNCTION IN SCHIZOPHRENIC PATIENTS FOLLOWING AN OLANZAPINE TREATMENT Schizophrenia Research. 117: 353. DOI: 10.1016/J.Schres.2010.02.619 |
0.461 |
|
| 2010 |
Guevremont C, Sablier J, Lum M, Vincent P, Tranulis C, Marcotte FN, Stip E. DOPILL, AN ELECTRONIC PILL DISPENSER, HELPING EVALUATE AND CONTROL MEDICATION ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 117: 278. DOI: 10.1016/J.Schres.2010.02.450 |
0.429 |
|
| 2010 |
Champagne-Lavau M, Stip E. Pragmatic and executive dysfunction in schizophrenia Journal of Neurolinguistics. 23: 285-296. DOI: 10.1016/J.Jneuroling.2009.08.009 |
0.506 |
|
| 2009 |
Aubin G, Chapparo C, Gélinas I, Stip E, Rainville C. Use of the Perceive, Recall, Plan and Perform System of Task Analysis for persons with schizophrenia: a preliminary study. Australian Occupational Therapy Journal. 56: 189-99. PMID 20854512 DOI: 10.1111/J.1440-1630.2007.00725.X |
0.388 |
|
| 2009 |
Potvin S, Blanchet P, Stip E. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophrenia Research. 113: 181-8. PMID 19608386 DOI: 10.1016/J.Schres.2009.06.010 |
0.517 |
|
| 2009 |
Guillem F, Satterthwaite J, Pampoulova T, Stip E. Relationship between psychotic and obsessive compulsive symptoms in schizophrenia. Schizophrenia Research. 115: 358-62. PMID 19560321 DOI: 10.1016/J.Schres.2009.06.004 |
0.528 |
|
| 2009 |
Champagne-Lavau M, Fossard M, Martel G, Chapdelaine C, Blouin G, Rodriguez JP, Stip E. Do patients with schizophrenia attribute mental states in a referential communication task? Cognitive Neuropsychiatry. 14: 217-39. PMID 19499387 DOI: 10.1080/13546800903004114 |
0.392 |
|
| 2009 |
Aubin G, Stip E, Gélinas I, Rainville C, Chapparo C. Daily functioning and information-processing skills among persons with schizophrenia. Psychiatric Services (Washington, D.C.). 60: 817-22. PMID 19487353 DOI: 10.1176/Ps.2009.60.6.817 |
0.441 |
|
| 2009 |
Lecardeur L, Stip E, Giguere M, Blouin G, Rodriguez JP, Champagne-Lavau M. Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study. Schizophrenia Research. 111: 153-8. PMID 19395240 DOI: 10.1016/J.Schres.2009.03.029 |
0.509 |
|
| 2009 |
Sablier J, Stip E, Franck N. Cognitive remediation and cognitive assistive technologies in schizophrenia | Remédiation cognitive et assistants cognitifs numériques dans la schizophrénie Encephale. 35: 160-167. PMID 19393385 DOI: 10.1016/J.Encep.2008.02.010 |
0.513 |
|
| 2009 |
Stip E, Letourneau G. Psychotic symptoms as a continuum between normality and pathology. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 140-51. PMID 19321018 DOI: 10.1177/070674370905400302 |
0.426 |
|
| 2009 |
Stip E. Psychosis: a category or a dimension? Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 137-9. PMID 19321017 DOI: 10.1177/070674370905400301 |
0.397 |
|
| 2009 |
Stip E, Mancini-Marïe A, Letourneau G, Fahim C, Mensour B, Crivello F, Dollfus S. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study. International Clinical Psychopharmacology. 24: 34-41. PMID 19077676 DOI: 10.1097/Yic.0B013E32831Daf6C |
0.434 |
|
| 2009 |
Lecardeur L, Briand C, Prouteau A, Lalonde P, Nicole L, Lesage A, Stip E. Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. Schizophrenia Research. 107: 303-6. PMID 18835134 DOI: 10.1016/J.Schres.2008.09.003 |
0.515 |
|
| 2009 |
Aubin G, Stip E, Gélinas I, Rainville C, Chapparo C. Daily activities, cognition and community functioning in persons with schizophrenia. Schizophrenia Research. 107: 313-8. PMID 18824328 DOI: 10.1016/J.Schres.2008.08.002 |
0.466 |
|
| 2009 |
Guillem F, Mendrek A, Lavoie ME, Pampoulova T, Stip E. Sex differences in memory processing in schizophrenia: an event-related potential (ERP) study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1-10. PMID 18727949 DOI: 10.1016/J.Pnpbp.2008.08.002 |
0.442 |
|
| 2009 |
Rouleau S, Saint-Jean M, Stip E, Fortier P. The Impact of a Pre-Vocational Program on Cognition, Symptoms, and Work Re-Integration in Schizophrenia Occupational Therapy in Mental Health. 25: 26-43. DOI: 10.1080/01642120802644904 |
0.429 |
|
| 2008 |
Tranulis C, Sepehry AA, Galinowski A, Stip E. Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 577-86. PMID 18801220 DOI: 10.1177/070674370805300904 |
0.321 |
|
| 2008 |
Lecardeur L, Dollfus S, Stip E. Semantic hyperpriming in schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 193: 82. PMID 18700231 DOI: 10.1192/Bjp.193.1.82 |
0.507 |
|
| 2008 |
Guillem F, Pampoulova T, Rinaldi M, Stip E. Temperament and executive dysfunctions in schizophrenia. Schizophrenia Research. 104: 175-84. PMID 18640010 DOI: 10.1016/J.Schres.2008.06.002 |
0.548 |
|
| 2008 |
Potvin S, Pampoulova T, Lipp O, Ait Bentaleb L, Lalonde P, Stip E. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cognitive Neuropsychiatry. 13: 357-66. PMID 18622790 DOI: 10.1080/13546800802264330 |
0.737 |
|
| 2008 |
Stip E, Mancini-Marïe A, Fahim C, Bentaleb LA, Létourneau G, Potvin S. Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients. Schizophrenia Research. 103: 319-21. PMID 18556174 DOI: 10.1016/J.Schres.2008.04.030 |
0.492 |
|
| 2008 |
Sengupta S, Parrilla-Escobar MA, Klink R, Fathalli F, Ying Kin Ng, Stip E, Baptista T, Malla A, Joober R. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophrenia Research. 102: 329-36. PMID 18396386 DOI: 10.1016/J.Schres.2008.02.013 |
0.407 |
|
| 2008 |
Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. Journal of Psychopharmacology (Oxford, England). 22: 262-9. PMID 18308802 DOI: 10.1177/0269881107083816 |
0.535 |
|
| 2008 |
Poulin J, Stip E, Godbout R. REM sleep EEG spectral analysis in patients with first-episode schizophrenia. Journal of Psychiatric Research. 42: 1086-93. PMID 18280502 DOI: 10.1016/J.Jpsychires.2008.01.003 |
0.384 |
|
| 2008 |
Thibault G, Felezeu M, O'Connor KP, Todorov C, Stip E, Lavoie ME. Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 803-15. PMID 18280023 DOI: 10.1016/J.Pnpbp.2007.12.016 |
0.319 |
|
| 2008 |
Guillem F, Rinaldi M, Pampoulova T, Stip E. The complex relationships between executive functions and positive symptoms in schizophrenia. Psychological Medicine. 38: 853-60. PMID 18261245 DOI: 10.1017/S0033291707002577 |
0.41 |
|
| 2008 |
Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. The American Journal of Drug and Alcohol Abuse. 34: 75-82. PMID 18161645 DOI: 10.1080/00952990701764631 |
0.446 |
|
| 2008 |
Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Safety. 31: 7-20. PMID 18095743 DOI: 10.2165/00002018-200831010-00002 |
0.326 |
|
| 2008 |
Potvin S, Stip E, Tempier A, Pampoulova T, Bentaleb LA, Lalonde P, Lipp O, Goffaux P, Marchand S. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. Journal of Psychiatric Research. 42: 1010-6. PMID 18093615 DOI: 10.1016/J.Jpsychires.2007.11.001 |
0.355 |
|
| 2008 |
O'Connor KP, Lavoie ME, Stip E, Borgeat F, Laverdure A. Cognitive-behaviour therapy and skilled motor performance in adults with chronic tic disorder. Neuropsychological Rehabilitation. 18: 45-64. PMID 18058387 DOI: 10.1080/09602010701390835 |
0.304 |
|
| 2008 |
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biological Psychiatry. 63: 801-8. PMID 18005941 DOI: 10.1016/J.Biopsych.2007.09.024 |
0.415 |
|
| 2008 |
Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophrenia Research. 100: 242-51. PMID 17614260 DOI: 10.1016/J.Schres.2007.04.022 |
0.478 |
|
| 2008 |
Mendrek A, Sepehry AA, Stip E. Toward a meta-analytic approach of sex differences in episodic memory of schizophrenia patients: Exploratory findings Clinical Schizophrenia and Related Psychoses. 2: 217-225. DOI: 10.3371/Csrp.2.3.3 |
0.404 |
|
| 2008 |
Mendrek A, Jimιnez J, Mancini-Maroe A, Fahim C, Stip E. Sex, sadness and schizophrenia: correlations between negative symptoms and cerebral activations Annals of General Psychiatry. 7. DOI: 10.1186/1744-859X-7-S1-S107 |
0.483 |
|
| 2008 |
Mendrek A, Jiménez J, Mancini-Marïe A, Rinaldi M, Stip E, Lavoie M, Guillem F. SEX DIFFERENCES IN CEREBRAL ACTIVATION DURING MENTAL ROTATION IN SCHIZOPHRENIA AND IN HEALTH Schizophrenia Research. 102: 89-90. DOI: 10.1016/S0920-9964(08)70272-X |
0.412 |
|
| 2008 |
Potvin S, Mancini-Marie A, Fahim C, Mensour B, Lèvesque J, Karama S, Beauregard M, Stip E. REGIONS OF INTEREST ANALYSES OF FRONTAL, TEMPORAL AND SUB-CORTICAL GREY MATTER IN SCHIZOPHRENIA USING VOXEL-BASED MORPHOMETRY Schizophrenia Research. 102: 82. DOI: 10.1016/S0920-9964(08)70250-0 |
0.424 |
|
| 2008 |
Mancini-Marïe A, Jimenez J, Corcoran C, Stip E, Rinaldi M, Mendrek A. REVERSED SEXUAL DIMORPHISM: PARIETAL CORTEX GREY MATTER DENSITY IN WOMEN AND MEN WITH SCHIZOPHRENIA COMPARED TO MATCHED HEALTHY CONTROLS USING 3 TESLA MRI Schizophrenia Research. 102: 71. DOI: 10.1016/S0920-9964(08)70220-2 |
0.372 |
|
| 2008 |
Stip E, Anselmo K, Dellamillieure P, Mancini-Marie A, Mendrek A, Ait Bentaleb L, Lipp O, Delisle M, Lalonde P, Léouffre P, Pampoulova T, Dollfus S. 12 – Olanzapine and cerebral mechanism involved in appetite and weight gain in schizophrenia: An fMRI study Schizophrenia Research. 98: 37. DOI: 10.1016/J.Schres.2007.12.079 |
0.329 |
|
| 2008 |
Champagne-Lavau M, Stip E, Blouin G, Rodriguez J. Does contextual information cue comprehension of speaker intent in schizophrenia? European Psychiatry. 23: S107. DOI: 10.1016/J.Eurpsy.2008.01.759 |
0.463 |
|
| 2008 |
Rinaldi M, Guillem F, Pampoulova T, Stip E. Symptom interactions and the neuropsychological correlates in schizophrenia Brain and Cognition. 67: 36. DOI: 10.1016/J.Bandc.2008.02.074 |
0.479 |
|
| 2008 |
Labelle V, Imbriglio TV, Thibault G, O’Connor K, Stip E, Lavoie ME. Effects of cognitive-behavioural therapy on neuropsychological performances in tic disorders Brain and Cognition. 67: 27. DOI: 10.1016/J.Bandc.2008.02.051 |
0.322 |
|
| 2008 |
Champagne-Lavau M, Chapdelaine C, Anselmo K, Stip E, Blouin G, Rodriguez J. Do patients with schizophrenia attribute intention and belief in a referential communication task? Brain and Cognition. 67: 16. DOI: 10.1016/J.Bandc.2008.02.026 |
0.449 |
|
| 2007 |
Potvin S, Mancini-Marie A, Fahim C, Mensour B, Stip E. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Social Neuroscience. 2: 106-16. PMID 18633810 DOI: 10.1080/17470910701376787 |
0.492 |
|
| 2007 |
Stip E, Sablier J, Sephery AA, Rivard S, Cloutier C, Aubin G, Godbout L, Limoges F. [Kitchen and schizophrenia: a crossroad activity of an ecological, occupational and neuropsychological assessment]. Santé Mentale Au QuéBec. 32: 159-79. PMID 18253666 DOI: 10.7202/016514Ar |
0.343 |
|
| 2007 |
Lecomte Y, Stip E, Caron J, Renaud S. [An exploratory study of adaptation of people with schizophrenia]. Santé Mentale Au QuéBec. 32: 137-58. PMID 18253665 DOI: 10.7202/016513Ar |
0.322 |
|
| 2007 |
Lecardeur L, Giffard B, Laisney M, Brazo P, Stip E, Eustache F, Dollfus S. Does hyperpriming reveal impaired spreading of activation in schizophrenia Schizophrenia Research. 97: 289-291. PMID 17855058 DOI: 10.1016/J.Schres.2007.08.017 |
0.383 |
|
| 2007 |
Potvin S, Sepehry AA, Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. The Australian and New Zealand Journal of Psychiatry. 41: 792-9. PMID 17828652 DOI: 10.1080/00048670701579041 |
0.419 |
|
| 2007 |
Stip E, Sepehry AA, Chouinard S. Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2. Clinical Neuropharmacology. 30: 218-29. PMID 17762319 DOI: 10.1097/Wnf.0B013E318059Be76 |
0.478 |
|
| 2007 |
Fahim C, Stip E, Mancini-Marïe A, Potvin S, Malaspina D. Orbitofrontal dysfunction in a monozygotic twin discordant for postpartum affective psychosis: a functional magnetic resonance imaging study. Bipolar Disorders. 9: 541-5. PMID 17680927 DOI: 10.1111/J.1399-5618.2007.00404.X |
0.383 |
|
| 2007 |
Chouinard S, Sepehry AA, Stip E. Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I. Clinical Neuropharmacology. 30: 169-82. PMID 17545751 DOI: 10.1097/Wnf.0B013E31802Fa61A |
0.505 |
|
| 2007 |
O'Connor K, Stip E, Pélissier MC, Aardema F, Guay S, Gaudette G, Van Haaster I, Robillard S, Grenier S, Careau Y, Doucet P, Leblanc V. Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 182-90. PMID 17479527 DOI: 10.1177/070674370705200310 |
0.418 |
|
| 2007 |
Sepehry AA, Potvin S, Elie R, Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. The Journal of Clinical Psychiatry. 68: 604-10. PMID 17474817 DOI: 10.4088/Jcp.V68N0417 |
0.457 |
|
| 2007 |
Mendrek A, Mancini-Marië A, Fahim C, Stip E. Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients. The Australian and New Zealand Journal of Psychiatry. 41: 136-41. PMID 17464691 DOI: 10.1080/00048670601109907 |
0.5 |
|
| 2007 |
Stip E, Corbière M, Boulay LJ, Lesage A, Lecomte T, Leclerc C, Ricard N, Cyr M, Guillem F. Intrusion errors in explicit memory: their differential relationship with clinical and social outcome in chronic schizophrenia. Cognitive Neuropsychiatry. 12: 112-27. PMID 17453894 DOI: 10.1080/13546800600809401 |
0.416 |
|
| 2007 |
Godbout L, Limoges F, Allard I, Braun CM, Stip E. Neuropsychological and activity of daily living script performance in patients with positive or negative schizophrenia. Comprehensive Psychiatry. 48: 293-302. PMID 17445526 DOI: 10.1016/J.Comppsych.2007.01.003 |
0.437 |
|
| 2007 |
Chouinard S, Stip E, Poulin J, Melun JP, Godbout R, Guillem F, Cohen H. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Current Medical Research and Opinion. 23: 575-83. PMID 17355738 DOI: 10.1185/030079906X167372 |
0.49 |
|
| 2007 |
Potvin S, Mancini-Marïe A, Fahim C, Mensour B, Lévesque J, Karama S, Beauregard M, Rompré PP, Stip E. Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Research. 154: 275-9. PMID 17341445 DOI: 10.1016/J.Pscychresns.2006.11.009 |
0.509 |
|
| 2007 |
Joyal CC, Putkonen A, Mancini-Marïe A, Hodgins S, Kononen M, Boulay L, Pihlajamaki M, Soininen H, Stip E, Tiihonen J, Aronen HJ. Violent persons with schizophrenia and comorbid disorders: a functional magnetic resonance imaging study. Schizophrenia Research. 91: 97-102. PMID 17291724 DOI: 10.1016/J.Schres.2006.12.014 |
0.346 |
|
| 2007 |
Champagne-Lavau M, Stip E, Joanette Y. Language functions in right-hemisphere damage and schizophrenia: apparently similar pragmatic deficits may hide profound differences. Brain : a Journal of Neurology. 130: e67; author reply e6. PMID 17235120 DOI: 10.1093/Brain/Awl311 |
0.402 |
|
| 2007 |
Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. European Psychiatry : the Journal of the Association of European Psychiatrists. 22: 104-15. PMID 17227707 DOI: 10.1016/J.Eurpsy.2006.11.004 |
0.529 |
|
| 2007 |
Forest G, Poulin J, Daoust AM, Lussier I, Stip E, Godbout R. Attention and non-REM sleep in neuroleptic-naive persons with schizophrenia and control participants. Psychiatry Research. 149: 33-40. PMID 17141330 DOI: 10.1016/J.Psychres.2005.11.005 |
0.346 |
|
| 2007 |
Guillaume F, Guillem F, Tiberghien G, Martin F, Ganeva E, Germain M, Pampoulova T, Stip E, Lalonde P. Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: familiarity, associative recollection and discriminative recollection. Psychiatry Research. 149: 105-19. PMID 17125845 DOI: 10.1016/J.Psychres.2006.03.015 |
0.453 |
|
| 2007 |
Stip E, Sepehry AA, Tempier A, Brochu-Blain A. [Differences and similarities in perception of schizophrenia between physicians and the general population in Quebec]. Sante Mentale Au Quebec. 31: 189-200. PMID 17111066 DOI: 10.7202/013692Ar |
0.442 |
|
| 2007 |
Potvin S, Sepehry AA, Stip E. Comorbid substance-use in schizophrenia: the file drawer effect, In reply to: Talamo et al., 2006. "Comorbid substance-use in schizophrenia: relation to positive and negative symptoms". Schizophrenia Research. 90: 351-2; author reply . PMID 17055705 DOI: 10.1016/J.Schres.2006.09.006 |
0.496 |
|
| 2006 |
Stip E, Langlois R, Thuot C, Mancini-Marïe A. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 297-300. PMID 16978752 DOI: 10.1016/J.Pnpbp.2006.08.005 |
0.41 |
|
| 2006 |
Stip E. [Cognition, schizophrenia and the effect of antipsychotics]. L'Encephale. 32: 341-50. PMID 16840928 DOI: 10.1016/S0013-7006(06)76162-0 |
0.447 |
|
| 2006 |
Briand C, Vasiliadis HM, Lesage A, Lalonde P, Stip E, Nicole L, Reinharz D, Prouteau A, Hamel V, Villeneuve K. Including integrated psychological treatment as part of standard medical therapy for patients with schizophrenia: clinical outcomes. The Journal of Nervous and Mental Disease. 194: 463-70. PMID 16840841 DOI: 10.1097/01.Nmd.0000225120.92431.29 |
0.44 |
|
| 2006 |
Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion. 22: 1277-85. PMID 16834826 DOI: 10.1185/030079906X112561 |
0.506 |
|
| 2006 |
Potvin S, Pampoulova T, Mancini-Marië A, Lipp O, Bouchard RH, Stip E. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 796-8. PMID 16705205 DOI: 10.1136/JNNP.2005.079228 |
0.399 |
|
| 2006 |
Mancini-Marïe A, Potvin S, Fahim C, Beauregard M, Mensour B, Stip E. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study. The Journal of Clinical Psychiatry. 67: 342-50. PMID 16649818 DOI: 10.4088/Jcp.V67N0302 |
0.504 |
|
| 2006 |
Ait Bentaleb L, Stip E, Mendrek A, Mensour B, Beauregard M. [Effects of listening to previously hallucinated words by schizophrenia patients in remission: a functional magnetic resonance imaging study of six cases]. L'EncéPhale. 32: 27-40. PMID 16633288 DOI: 10.1016/S0013-7006(06)76134-6 |
0.456 |
|
| 2006 |
Guillem F, Chouinard S, Poulin J, Godbout R, Lalonde P, Melun P, Bentaleb LA, Stip E. Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30: 934-45. PMID 16580765 DOI: 10.1016/J.Pnpbp.2006.02.009 |
0.371 |
|
| 2006 |
Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine. 36: 431-40. PMID 16536885 DOI: 10.1017/S003329170500574X |
0.474 |
|
| 2006 |
Tranulis C, Mouaffak F, Chouchana L, Stip E, Gourevitch R, Poirier MF, Olié JP, Lôo H, Gourion D. Somatic augmentation strategies in clozapine resistance--what facts? Clinical Neuropharmacology. 29: 34-44. PMID 16518133 DOI: 10.1097/00002826-200601000-00010 |
0.304 |
|
| 2006 |
Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. The New England Journal of Medicine. 354: 472-82. PMID 16452559 DOI: 10.1056/Nejmoa053222 |
0.463 |
|
| 2006 |
Caron J, Lecomte Y, Stip E, Renaud S. Predictors of quality of life in schizophrenia. Community Mental Health Journal. 41: 399-417. PMID 16335350 DOI: 10.1007/S10597-005-5077-8 |
0.373 |
|
| 2006 |
Champagne-Lavau M, Stip E, Joanette Y. Social Cognition Deficit in Schizophrenia: Accounting for Pragmatic Deficits in Communication Abilities? Current Psychiatry Reviews. 2: 309-315. DOI: 10.2174/157340006778018184 |
0.368 |
|
| 2006 |
Stip E, Caron J, Mancini-Marïe A. General population perceptions and attitudes towards schizophrenia and bipolar disorder Primary Care and Community Psychiatry. 11: 157-165. DOI: 10.1185/135525707X183003 |
0.457 |
|
| 2005 |
Woodward TS, Whitman JC, Arbuthnott K, Kragelj TL, Lyons J, Stip E. Visual search irregularities in schizophrenia depend on display size switching. Cognitive Neuropsychiatry. 10: 137-52. PMID 16571457 DOI: 10.1080/13546800344000010 |
0.358 |
|
| 2005 |
Caron J, Mercier C, Martin A, Stip E. [The role of social support, family burden and satisfaction with services in psychological distress and quality of life of families of individuals with schizophrenia]. Santé Mentale Au QuéBec. 30: 165-91. PMID 16505930 DOI: 10.7202/012144Ar |
0.319 |
|
| 2005 |
Stip E, Fahim C, Liddle P, Mancini-Marïe A, Mensour B, Bentaleb LA, Beauregard M. Neural correlates of sad feelings in schizophrenia with and without blunted affect. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 50: 909-17. PMID 16494260 DOI: 10.1177/070674370505001405 |
0.429 |
|
| 2005 |
Briand C, Bélanger R, Hamel V, Nicole L, Stip E, Reinharz D, Lalonde P, Lesage A. [Implementation of the multi-site Integrated Psychological Treatment (IPT) program for people with schizophrenia. Elaboration of renewed version]. Santé Mentale Au QuéBec. 30: 73-95. PMID 16170424 DOI: 10.7202/011162Ar |
0.383 |
|
| 2005 |
Fahim C, Stip E, Mancini-Marïe A, Mensour B, Boulay LJ, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M. Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Research. 140: 1-15. PMID 16143498 DOI: 10.1016/J.Pscychresns.2005.06.003 |
0.311 |
|
| 2005 |
Stip E, Sepehry AA, Prouteau A, Briand C, Nicole L, Lalonde P, Lesage A. Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain and Cognition. 59: 292-5. PMID 16125294 DOI: 10.1016/J.Bandc.2005.07.003 |
0.528 |
|
| 2005 |
Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophrenia Research. 77: 343-53. PMID 16085207 DOI: 10.1016/J.Schres.2005.03.001 |
0.385 |
|
| 2005 |
Stip E, Trudeau LE. Glycine and D-serine improve the negative symptoms of schizophrenia. Evidence-Based Mental Health. 8: 82. PMID 16043624 DOI: 10.1136/ebmh.8.3.82 |
0.363 |
|
| 2005 |
Fahim C, Stip E, Mancini-Marïe A, Gendron A, Mensour B, Beauregard M. Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. Journal of Clinical Psychopharmacology. 25: 367-71. PMID 16012281 DOI: 10.1097/01.Jcp.0000168880.10793.Ed |
0.377 |
|
| 2005 |
Stip E, Rialle V. Environmental cognitive remediation in schizophrenia: ethical implications of "smart home" technology. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 50: 281-91. PMID 15968845 DOI: 10.1177/070674370505000509 |
0.429 |
|
| 2005 |
Remington G, Chue P, Stip E, Kopala L, Girard T, Christensen B. The crossover approach to switching antipsychotics: what is the evidence? Schizophrenia Research. 76: 267-72. PMID 15949658 DOI: 10.1016/J.Schres.2005.01.009 |
0.3 |
|
| 2005 |
Potvin S, Briand C, Prouteau A, Bouchard RH, Lipp O, Lalonde P, Nicole L, Lesage A, Stip E. CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition. 59: 38-42. PMID 15913868 DOI: 10.1016/J.Bandc.2005.04.002 |
0.551 |
|
| 2005 |
Guillem F, Pampoulova T, Stip E, Todorov C, Lalonde P. Are there common mechanisms in sensation seeking and reality distortion in schizophrenia? A study using memory event-related potentials. Psychiatry Research. 135: 11-33. PMID 15893383 DOI: 10.1016/J.Psychres.2004.11.008 |
0.498 |
|
| 2005 |
Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E. The paradox of quetiapine in obsessive-compulsive disorder. Cns Spectrums. 10: 356-61. PMID 15858452 DOI: 10.1017/S1092852900022719 |
0.518 |
|
| 2005 |
Guillem F, Pampoulova T, Stip E, Lalonde P, Todorov C. The relationships between symptom dimensions and dysphoria in schizophrenia. Schizophrenia Research. 75: 83-96. PMID 15820327 DOI: 10.1016/J.Schres.2004.06.018 |
0.496 |
|
| 2005 |
Stip E, Chouinard S, Boulay LJ. On the trail of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 219-32. PMID 15694228 DOI: 10.1016/J.Pnpbp.2004.11.004 |
0.457 |
|
| 2005 |
Guillem F, Ganeva E, Pampoulova T, Stip E, Lalonde P, Sasseville M. Changes in the neuropsychological correlates of clinical dimensions between the acute and stable phase of schizophrenia. Brain and Cognition. 57: 93-101. PMID 15629220 DOI: 10.1016/J.Bandc.2004.08.027 |
0.395 |
|
| 2005 |
Stip E, Fahim C, Mancini-Marïe A, Bentaleb LA, Mensour B, Mendrek A, Beauregard M. Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 21-6. PMID 15610941 DOI: 10.1016/J.Pnpbp.2004.08.015 |
0.462 |
|
| 2005 |
Potvin S, Stip E, Roy J. Toxic Psychoses as Pharmacological Models of Schizophrenia Current Psychiatry Reviews. 1: 23-32. DOI: 10.2174/1573400052953583 |
0.545 |
|
| 2005 |
Stip E, Trudeau LE. Glycine and D-serine improve the negative symptoms of schizophrenia: Commentary Evidence-Based Mental Health. 8: 82. DOI: 10.1136/Ebmh.8.3.82 |
0.421 |
|
| 2005 |
Guillem F, Pampoulova T, Stip E, Lalonde P, Todorov C. Erratum to “The relationships between symptom dimensions and dysphoria in schizophrenia” [Schizophrenia Research 75/1 (2005) 83–96] Schizophrenia Research. 77: 117-118. DOI: 10.1016/J.Schres.2005.04.009 |
0.463 |
|
| 2004 |
Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin. 30: 957-67. PMID 15954201 DOI: 10.1093/Oxfordjournals.Schbul.A007145 |
0.349 |
|
| 2004 |
Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E. The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Psychiatry Research. 129: 171-7. PMID 15590044 DOI: 10.1016/J.Psychres.2004.07.005 |
0.44 |
|
| 2004 |
Potvin S, Stip E, Roy JY. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 711. PMID 15560324 DOI: 10.1177/070674370404901020 |
0.47 |
|
| 2004 |
Semkovska M, Bédard MA, Godbout L, Limoge F, Stip E. Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophrenia Research. 69: 289-300. PMID 15469200 DOI: 10.1016/J.Schres.2003.07.005 |
0.499 |
|
| 2004 |
Mendrek A, Laurens KR, Kiehl KA, Ngan ET, Stip E, Liddle PF. Changes in distributed neural circuitry function in patients with first-episode schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 185: 205-14. PMID 15339824 DOI: 10.1192/Bjp.185.3.205 |
0.491 |
|
| 2004 |
Fahim C, Stip E, Mancini-Marïe A, Boualem M, Malaspina D, Beauregard M. Negative socio-emotional resonance in schizophrenia: a functional magnetic resonance imaging hypothesis. Medical Hypotheses. 63: 467-75. PMID 15288371 DOI: 10.1016/J.Mehy.2004.01.035 |
0.339 |
|
| 2004 |
Stip E, Bigras MJ, Mancini-Marïe A, Cosset ME, Black D, Lecours AR. Long-term effect of prefrontal lobotomy on verbal fluency in patients with schizophrenia. Brain and Cognition. 55: 466-9. PMID 15223191 DOI: 10.1016/J.Bandc.2004.02.067 |
0.493 |
|
| 2004 |
Stip E, Mancini-Marïe A. Cognitive function and depression in symptom resolution in schizophrenia patients treated with an atypical antipsychotic. Brain and Cognition. 55: 463-5. PMID 15223190 DOI: 10.1016/J.Bandc.2004.02.066 |
0.506 |
|
| 2004 |
Scherer H, Bedard MA, Stip E, Paquet F, Richer F, Bériault M, Rodriguez JP, Motard JP. Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 17: 32-40. PMID 15209223 DOI: 10.1097/00146965-200403000-00004 |
0.428 |
|
| 2004 |
Milovan DL, Baribeau J, Roth RM, Stip E. ERP study of pre-attentive auditory processing in treatment-refractory schizophrenia. Brain and Cognition. 55: 355-7. PMID 15177812 DOI: 10.1016/J.Bandc.2004.02.045 |
0.464 |
|
| 2004 |
Fahim C, Stip E, Mancini-Marïe A, Beauregard M. Genes and memory: the neuroanatomical correlates of emotional memory in monozygotic twin discordant for schizophrenia. Brain and Cognition. 55: 250-3. PMID 15177789 DOI: 10.1016/J.Bandc.2004.02.023 |
0.466 |
|
| 2004 |
Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E. Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophrenia Research. 69: 85-91. PMID 15145474 DOI: 10.1016/J.Schres.2003.08.011 |
0.435 |
|
| 2004 |
Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 47-56. PMID 14990759 DOI: 10.1176/Jnp.16.1.47 |
0.301 |
|
| 2004 |
Chue P, Stip E, Remington G, Kopala L. Switching atypical antipsychotics: A review Acta Neuropsychiatrica. 16: 301-313. DOI: 10.1111/J.0924-2708.2004.00098.X |
0.381 |
|
| 2003 |
Stip E, Caron J, Renaud S, Pampoulova T, Lecomte Y. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Comprehensive Psychiatry. 44: 331-40. PMID 12923712 DOI: 10.1016/S0010-440X(03)00086-5 |
0.482 |
|
| 2003 |
Stip E, Remington GJ, Dursun SM, Reiss JP, Rotstein E, MacEwan GW, Chokka PR, Jones B, Dickson RA. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine. Journal of Clinical Psychopharmacology. 23: 400-4. PMID 12920417 DOI: 10.1097/01.Jcp.0000085414.08426.8F |
0.454 |
|
| 2003 |
Purdon SE, Woodward N, Lindborg SR, Stip E. Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol Psychopharmacology. 169: 390-397. PMID 12827347 DOI: 10.1007/S00213-003-1505-Z |
0.362 |
|
| 2003 |
Poulin J, Daoust AM, Forest G, Stip E, Godbout R. Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophrenia Research. 62: 147-53. PMID 12765755 DOI: 10.1016/S0920-9964(02)00346-8 |
0.343 |
|
| 2003 |
Potvin S, Stip E, Roy JY. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. International Clinical Psychopharmacology. 18: 121-32. PMID 12702890 DOI: 10.1097/01.Yic.0000063501.97247.38 |
0.452 |
|
| 2003 |
Schérer H, Stip E, Paquet F, Bédard MA. Mild procedural learning disturbances in neuroleptic-naive patients with schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 58-63. PMID 12556572 DOI: 10.1176/Jnp.15.1.58 |
0.436 |
|
| 2003 |
Stip E. Book Review: Schizophrenia Revealed: From Neurons to Social Interactions The Canadian Journal of Psychiatry. 48: 137-139. DOI: 10.1177/070674370304800226 |
0.396 |
|
| 2003 |
Prouteau A, Stip E, Mancini-Marie A, Briand C, Nicole L, Lalonde P, Reinhartz D, Lesage A, Verdoux H. Subjective representation of cognitive deficit measured with cantab in schizophrenia Schizophrenia Research. 60: 179. DOI: 10.1016/S0920-9964(03)81066-6 |
0.406 |
|
| 2003 |
Semkovska M, Barbo E, Stip E, Bedard M. Comparison of script knowledge and script execution of a daily activity in schizophrenia Schizophrenia Research. 60: 157. DOI: 10.1016/S0920-9964(03)80997-0 |
0.487 |
|
| 2003 |
Poulin J, Stip E, Godbout R. REM sleep EEG activity correlates with cognitive performance in first-episode, neuroleptic-naive patients with schizophrenia Schizophrenia Research. 60: 152. DOI: 10.1016/S0920-9964(03)80981-7 |
0.44 |
|
| 2003 |
Chouinard S, Stip E, Comtois G, Corbiere M, Bole´ P, Lamontagne L, Lecavalier M, Lalonde P, Beauregard F. Profile of cognitive functioning in patients with schizophrenia in specialized classes Schizophrenia Research. 60: 129-130. DOI: 10.1016/S0920-9964(03)80911-8 |
0.508 |
|
| 2003 |
Briand C, Lesage A, Lalonde P, Stip E, Nicole L, Reinharz D, Prouteau A, Snyders J, Villeneuve K. The integrated psychological treatment (IPT) for patients with schizophrenia: Evidence of effectiveness during program implementation in various sites in Quebec, Canada Schizophrenia Research. 60: 320. DOI: 10.1016/S0920-9964(03)80275-X |
0.433 |
|
| 2003 |
Stip E, Mancini A, Fahim C. September 11, 2001: A fair degree of indifference in schizophrenia Schizophrenia Research. 60: 26. DOI: 10.1016/S0920-9964(03)80077-4 |
0.416 |
|
| 2003 |
Guillem F, Pampoulova T, Stip E, Sasseville M, Luyet A. Personality and symptom dimensions in acute schizophrenia Schizophrenia Research. 60: 16-17. DOI: 10.1016/S0920-9964(03)80046-4 |
0.465 |
|
| 2002 |
Stip E. Happy birthday neuroleptics! 50 years later: la folie du doute. European Psychiatry : the Journal of the Association of European Psychiatrists. 17: 115-9. PMID 12052571 DOI: 10.1016/S0924-9338(02)00639-9 |
0.4 |
|
| 2001 |
O'Connor KP, Brault M, Robillard S, Loiselle J, Borgeat F, Stip E. Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders Behaviour Research and Therapy. 39: 667-681. PMID 11400711 DOI: 10.1016/S0005-7967(00)00048-6 |
0.325 |
|
| 2001 |
Lussier I, Stip E. Memory and attention deficits in drug naive patients with schizophrenia. Schizophrenia Research. 48: 45-55. PMID 11278153 DOI: 10.1016/S0920-9964(00)00102-X |
0.465 |
|
| 2001 |
Stip É. Book Review: Psychopathologie cognitive: La psychopathologie cognitiveLa psychopathologie cognitive. Besche-RichardChrystel. Paris: Presse Universitaires de France; 2000. 125 p. The Canadian Journal of Psychiatry. 46: 282-283. DOI: 10.1177/070674370104600310 |
0.315 |
|
| 2001 |
Stip E. Haloperidol-to-ziprasidone switching strategies in schizophrenia European Neuropsychopharmacology. 11: S272. DOI: 10.1016/S0924-977X(01)80337-0 |
0.386 |
|
| 2001 |
Stip E. Discriminant cognitive factors according to treatment response and to antipsychotic drugs in patients with schizophrenia: Issues on practice effect, dosing, D2 occupancy, and procedural learning European Neuropsychopharmacology. 11: S134-S135. DOI: 10.1016/S0924-977X(01)80060-2 |
0.446 |
|
| 2000 |
Ait Bentaleb L, Stip E, Beauregard M. [Psychopathology and neurobiological bases of auditory hallucinations in schizophrenia.]. Santé Mentale Au QuéBec. 25: 241-57. PMID 18253579 |
0.43 |
|
| 2000 |
Black DN, Stip E, Bédard M, Kabay M, Paquette I, Bigras MJ. Leukotomy revisited: late cognitive and behavioral effects in chronic institutionalized schizophrenics. Schizophrenia Research. 43: 57-64. PMID 10828415 DOI: 10.1016/S0920-9964(99)00176-0 |
0.45 |
|
| 2000 |
Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Archives of General Psychiatry. 57: 249-58. PMID 10711911 DOI: 10.1001/ARCHPSYC.57.3.249 |
0.395 |
|
| 2000 |
Mendrek A, Laurens K, Kiehl K, Ngan E, Stip E, Liddle P. An fMRI investigation of cerebral state and trait markers of schizophrenia Neuroimage. 11. DOI: 10.1016/S1053-8119(00)91154-6 |
0.447 |
|
| 1999 |
Stip E, Lussier I, Ngan E, Mendrek A, Liddle P. Discriminant cognitive factors in responder and non-responder patients with schizophrenia. European Psychiatry : the Journal of the Association of European Psychiatrists. 14: 442-50. PMID 10683630 DOI: 10.1016/S0924-9338(99)00223-0 |
0.507 |
|
| 1999 |
Stip E, Furlan M, Lussier I, Bourgouin P, Elie R. Double-blind, placebo-controlled study comparing effects of zopiclone and temazepam on cognitive functioning of insomniacs Human Psychopharmacology. 14: 253-261. DOI: 10.1002/(Sici)1099-1077(199906)14:4<253::Aid-Hup97>3.0.Co;2-I |
0.349 |
|
| 1998 |
Lussier I, Stip E. The Effect of Risperidone on Cognitive and Psychopathological Manifestations of Schizophrenia Cns Spectrums. 3: 55-69. DOI: 10.1017/S1092852900006660 |
0.479 |
|
| 1997 |
Stip E. From intrapsychic ataxia to cognitive dysmetria: from Stransky to Andreasen. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 777. PMID 9307839 DOI: 10.1177/070674379704200716 |
0.309 |
|
| 1997 |
Stip E, Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: S35-40. PMID 8899249 DOI: 10.1177/070674379604100802 |
0.471 |
|
| 1997 |
Stip E. Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: S27-34. PMID 8899248 DOI: 10.1177/070674379604100822 |
0.491 |
|
| 1997 |
Bédard MA, Scherer H, Delorimier J, Stip E, Lalonde P. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: S21-4. PMID 8884048 DOI: 10.1177/070674379604100704 |
0.327 |
|
| 1997 |
Stip E, Lussier I. The heterogeneity of memory dysfunction in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: S14-20. PMID 8884047 DOI: 10.1177/070674379604100703 |
0.432 |
|
| 1997 |
Lussier I, Stip E, Coyette F. Explicit and implicit memory functioning in first episode and chronic schizophrenic patients, in comparison to brain damaged amnesic patients Schizophrenia Research. 24: 113. DOI: 10.1016/S0920-9964(97)82316-X |
0.309 |
|
| 1996 |
Stip E, Lussier I, Babai M, Fabian JL, Link C. Seroquel and cognitive improvement in patients with schizophrenia. Biological Psychiatry. 40: 434-5. PMID 8874852 DOI: 10.1016/0006-3223(96)82520-0 |
0.531 |
|
| 1996 |
Stip E, Lussier I. The Effect of Risperidone on Cognition in Patients with Schizophrenia The Canadian Journal of Psychiatry. 41: S35-S40. DOI: 10.1177/070674379604100823 |
0.446 |
|
| 1996 |
Stip E. Memory Impairment in Schizophrenia: Perspectives from Psychopathology and Pharmacotherapy The Canadian Journal of Psychiatry. 41: S27-S34. DOI: 10.1177/070674379604100801 |
0.385 |
|
| 1995 |
Stip E, Lussier I, Babai M, Debruille B, AndréBédard M. Cognitive decline in young drugnaive schizophrenics Schizophrenia Research. 15: 135. DOI: 10.1016/0920-9964(95)95419-A |
0.343 |
|
| 1993 |
Stip E, Perreault MC. Phantom limb in schizophrenia and the central hypothesis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 38: 151-3. PMID 8467442 DOI: 10.1177/070674379303800217 |
0.502 |
|
| Show low-probability matches. |